Purchases and Sales Made in Q4 2022 in Century Therapeutics, Inc. (IPSC)
This table provides information about the institutional ownership of Century Therapeutics, Inc. (IPSC) during Q4 2022. The information is specifically focused on institutions that hold shares of Century Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-120- 11.92% |
$581 - $1.39K
|
887
$1.45K
|
|
|
Feb 13, 2023
Q4 2022
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-3.07K- 12.46% |
$14.8K - $35.5K
|
21.5K
$35.1K
|
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-15.7K- 20.77% |
$76.2K - $182K
|
60K
$97.9K
|
|
|
Feb 14, 2023
Q4 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-83.1K- 50.3% |
$402K - $962K
|
82.1K
$134K
|
|
|
Feb 14, 2023
Q4 2022
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
SELL
|
- |
-117K- 19.13% |
$569K - $1.36M
|
497K
$809K
|
|
|
Feb 14, 2023
Q4 2022
|
Octagon Capital Advisors LP
New York, NY |
SELL
|
- |
-215K- 82.69% |
$1.04M - $2.49M
|
45K
$73.4K
|
|
|
Feb 14, 2023
Q4 2022
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-229K- 24.74% |
$1.11M - $2.65M
|
696K
$1.13M
|
|
|
Feb 14, 2023
Q4 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-644K- 91.8% |
$3.12M - $7.46M
|
57.5K
$93.7K
|